SOX2OT, a novel tumor-related long non-coding RNA

Area of Science:

• Molecular Biology
• Genetics
• Oncology

Background:

• SOX2OT is a long non-coding RNA highly expressed in embryonic stem cells.
• Its gene structure involves 10 exons and multiple transcription start sites.
• SOX2OT dysregulation is implicated in a wide range of human cancers.

Purpose of the Study:

• To review the current evidence on the role of SOX2OT in human cancers.
• To explore the potential clinical utility of SOX2OT in cancer diagnosis and treatment.

Main Methods:

• Literature review of studies investigating SOX2OT in various cancer types.
• Analysis of molecular mechanisms and signaling pathways associated with SOX2OT function.

Main Results:

• SOX2OT typically functions as an oncogene but can also act as a tumor suppressor.
• Its dysregulation is observed in lung, breast, liver, ovarian, pancreatic, and other cancers.
• The mechanisms of SOX2OT action are complex, involving multiple factors and pathways.

Conclusions:

• SOX2OT plays a significant and multifaceted role in human oncogenesis.
• Understanding SOX2OT's function may offer new avenues for cancer therapy and clinical applications.